A trial of blocking pain around knee joint by alcohol or phenol based intervention.

Efficacy of USG guided genicular nerve block with aqueous phenol(6%),ethyl alcohol(95%) and triamcinolone(20mg)with lignocaine(2%)-a randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070562

Enrollment

Registered

2024-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: USG guided genicular nerve block: USG guided genicular nerve block in three sites namely superomedial superolateral and inferomedial area of knee joint with 3 ml aqueous phenol 6% on ea

Eligibility

Inclusion criteria

Inclusion criteria: Patients from out patient department during the study primary osteoarthritis knee age between 40 to 60 years both gender clinically and radiologically confirmed for at least 3 months of duration

Exclusion criteria

Exclusion criteria: Patients with secondary osteoarthritis knee grade I and II osteoarthritis knee KL grading patients with uncontrolled comorbidities patients who got intraarticular injection in knee joint within last 3 months patients of syndrome complex not willing to give consent with psychiatric disorder of malignancy of bleeding diathesis with history of allergy of any of the pharmacological agents with infection either systemic or local history of knee surgery with anticoagulant medications

Design outcomes

Primary

Measure	Time frame
General Objective is to evaluate reduction of pain in VAS Scale in grade III and grade IV osteoarthritis Knee as per KL grading Specific Objectives are to assess the improvement in knee pain and quality of life in KOOS Scale to find out the improvement in the sleep quality in Pittsburgh sleep quality index PSQI scale to identify the side effects if any due to intervention Timepoint: outcome will be assessed at baseline or 0 week 4th week 12th week and at 24th week	—

Measure

Time frame

General Objective is to evaluate reduction of pain in VAS Scale in grade III and grade IV osteoarthritis Knee as per KL grading Specific Objectives are to assess the improvement in knee pain and quality of life in KOOS Scale to find out the improvement in the sleep quality in Pittsburgh sleep quality index PSQI scale to identify the side effects if any due to intervention Timepoint: outcome will be assessed at baseline or 0 week 4th week 12th week and at 24th week

—

Secondary

Measure	Time frame
To assess the improvement in knee pain quality of life in KOOS Scale to find out the improvement in sleep quality in Pittsburgh sleep quality index PSQI scale to identify the side effects if any due to interventionTimepoint: Outcome will be assessed at baseline or 0 week 4th week 12th week 24th week	—

Countries

India

Contacts

Public ContactNIBEDITA MALIK

Nil Ratan Sircar Medical College and Hospital

drsaumen16@yahoo.com9433124596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026